OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class …
( read original story …)

---